1.
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
by Kakkar, Ajay K, Prof
The Lancet (British edition), 2008, Vol.372 (9632), p.31-39
2.
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
by Goette, Andreas, Prof
The Lancet (British edition), 2016, Vol.388 (10055), p.1995-2003
3.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
by Eriksson, Bengt I, Dr
The Lancet (British edition), 2007, Vol.370 (9591), p.949-956
4.
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
by Aujesky, Drahomir, Prof
The Lancet (British edition), 2011, Vol.378 (9785), p.41-48
5.
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
by Lassen, Michael Rud, Dr
The Lancet (British edition), 2010, Vol.375 (9717), p.807-815
6.
Effective use of weight-based enoxaparin for deep vein thrombosis chemoprophylaxis in patients with traumatic brain injury
by Taylor, Ashley
The American journal of surgery, 2022, Vol.223 (1), p.146-150
7.
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
by Turpie, Alexander GG, MD
The Lancet (British edition), 2009, Vol.373 (9676), p.1673-1680
8.
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison
by Lassen, Michael Rud
The Lancet (British edition), 2002, Vol.359 (9319), p.1715-1720
9.
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial
by Turpie, Alexander GG
The Lancet (British edition), 2002, Vol.359 (9319), p.1721-1726
10.
Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
by Kleber, Franz-Xaver
The American heart journal, 2003, Vol.145 (4), p.614-621
11.
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
by The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
The Lancet (British edition), 2001, Vol.358 (9282), p.605-613
12.
Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits
by Dudley, Roy R
Journal of neurotrauma, 2010, Vol.27 (12), p.2165-2172
13.
Scientific considerations in the review and approval of generic enoxaparin in the United States
by Lee, Sau
Nature biotechnology, 2013, Vol.31 (3), p.220-226
14.
Utility of anti-Factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis
by Pannucci, Christopher J., MD MS
The American journal of surgery, 2016, Vol.213 (6), p.1143-1152
15.
Assessing an enoxaparin dosing protocol in morbidly obese patients
by Lalama, Jeffrey T
Journal of thrombosis and thrombolysis, 2014, Vol.39 (4), p.516-521
16.
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
by Lu, Genmin
Nature medicine, 2013, Vol.19 (4), p.446-451
17.
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
by Valgimigli, Marco, Dr
The Lancet (British edition), 2015, Vol.385 (9986), p.2465-2476
18.
Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient
by Bickford, Annika, P.A.-C., M.P.A.S
The American journal of surgery, 2013, Vol.206 (6), p.847-852
19.
Early thromboembolic prophylaxis in patients with blunt solid abdominal organ injuries undergoing nonoperative management: is it safe?
by Joseph, Bellal, M.D
The American journal of surgery, 2015, Vol.209 (1), p.194-198
20.
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery
by Wolowacz, Sorrel E., PhD
Clinical therapeutics, 2009, Vol.31 (1), p.194-212
